Ocular malignancies, encompassing both childhood and adult cancers such as retinoblastoma and uveal melanoma, are rare but pose significant challenges to the medical community and affected individuals (Dimaras et al., 2012; Singh et al., 2011). Only a few new cases are diagnosed yearly, making it difficult to gather large-scale data and conduct comprehensive epidemiological studies (Rodriguez-Galindo et al., 2015; Virgili et al., 2017). The Surveillance, Epidemiology, and End Results (SEER) program, a major source of cancer data in the United States, covers only 10-30% of the population (Howlader et al., 2021). This limited coverage may not fully represent the national incidence, prevalence, and outcomes of ocular malignancies.